Nonconventional MRI and microstructural cerebral changes in multiple sclerosis

Nature Reviews Neurology

Volumn 11, Issue 12, 2015, Pages 676-686

  Enzinger, Christian ^a,b   Barkhof, Frederik ^c   Ciccarelli, Olga ^d   Filippi, Massimo ^e   Kappos, Ludwig ^f   Rocca, Maria A ^e   Ropele, Stefan ^b   Rovira, Àlex ^g   Schneider, Torben ^d   De Stefano, Nicola ^h   Vrenken, Hugo ^c   Wheeler Kingshott, Claudia ^d   Wuerfel, Jens ⁱ   Fazekas, Franz ^b  

^a Division of Neuroradiology   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF BASEL   (Switzerland)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF SIENA   (Italy)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ELASTOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE ELASTOGRAPHY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SUSCEPTIBILITY WEIGHTED IMAGING; BRAIN CORTEX; BRAIN MAPPING; IMAGE PROCESSING; NEUROIMAGING; PATHOLOGY;

BRAIN MAPPING; CEREBRAL CORTEX; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTIPLE SCLEROSIS; NEUROIMAGING;

EID: 84949322673     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.194     Document Type: Review

References (131)

1. Rovira, À. et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat. Rev. Neurol. 11, 471-482 (2015).
2. Wattjes, M. et al. MAGNIMS consensus guidelines on the use of MRi in multiple sclerosis-establishing disease prognosis and monitoring patients. Nat. Rev. Neurol. 11, 597-606 (2015).
3. Filippi, M., Agosta, F. Imaging biomarkers in multiple sclerosis. J. Magn. Reson. Imaging 31, 770-788 (2010).
4. Filippi, M. et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 11, 349-360 (2012).
5. Henkelman, R. M. et al. Quantitative interpretation of magnetization transfer. Magn. Reson. Med. 29, 759-766 (1993).
6. Henkelman, R., Stanisz, G & Graham, S. J. Magnetization transfer in MRI: a review. NMR Biomed. 14, 57-64 (2001).
7. Sled, J. G., Pike, G. B. Quantitative interpretation of magnetization transfer in spoiled gradient echo MRI sequences. J. Magn. Reson. 145, 24-36 (2000).
8. Garcia, M. et al. Fast high-resolution brain imaging with balanced SSFP: interpretation of quantitative magnetization transfer towards simple MTR. Neuroimage 59, 202-211 (2012).
9. Amann, M. et al. Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations. Neuroimage 108, 87-94 (2015).
10. Bieri, O., Scheffler, K. Optimized balanced steady-state free precession magnetization transfer imaging. Magn. Reson. Med. 58, 511-518 (2007).
11. Yarnykh, V. L. Fast macromolecular proton fraction mapping from a single off-resonance magnetization transfer measurement. Magn. Reson. Med. 68, 166-178 (2012).
12. Mangia, S., De Martino, F., Liimatainen, T., Garwood, M., Michaeli, S. Magnetization transfer using inversion recovery during off-resonance irradiation. Magn. Reson. Imaging 29, 1346-1350 (2011).
13. Li, K. et al. Optimized inversion recovery sequences for quantitative T1 and magnetization transfer imaging. Magn. Reson. Med. 64, 491-500 (2010).
14. Wu, Y. et al. Comprehensive brain analysis with automated high-resolution magnetization transfer measurements. J. Magn. Reson. Imaging 35, 309-317 (2012).
15. Soellinger, M., Langkammer, C., Seifert-Held, T., Fazekas, F., Ropele, S. Fast bound pool fraction mapping using stimulated echoes. Magn. Reson. Med. 66, 717-724 (2011).
16. Helms, G., Dathe, H., Kallenberg, K., Dechent, P. High-resolution maps of magnetization transfer with inherent correction for RF inhomogeneity and T1 relaxation obtained from 3D FLASH MRI. Magn. Reson. Med. 60, 1396-1407 (2008).
17. Varma, G., Duhamel, G., de Bazelaire, C., Alsop, D. C. Magnetization transfer from inhomogeneously broadened lines: a potential marker for myelin. Magn. Reson. Med. 73, 614-622 (2015).
18. Girard, O. M. et al. Magnetization transfer from inhomogeneously broadened lines (ihMT): experimental optimization of saturation parameters for human brain imaging at 1.5 Tesla. Magn. Reson. Med. 73, 2111-2121 (2015).
19. Lee, J. S., Xia, D., Ge, Y., Jerschow, A., Regatte, R. R. Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI. Neuroimage 95, 22-28 (2014).
20. Ropele, S., Fazekas, F. Magnetization transfer MR imaging in multiple sclerosis. Neuroimaging Clin. N. Am. 19, 27-36 (2009).
21. Schmierer, K., Scaravilli, F., Altmann, D. R., Barker, G. J., Miller, D. H. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann. Neurol. 56, 407-415 (2004).
22. Bot, J. C. et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 233, 531-540 (2004).
23. Filippi, M. et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch. Neurol. 68, 1514-1520 (2011).
24. Fazekas, F., Ropele, S., Enzinger, C., Seifert, T., Strasser-Fuchs, S. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult. Scler. 8, 479-484 (2002).
25. Chen, J. T. et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann. Neurol. 63, 254-262 (2008).
26. Agosta, F. et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 129, 2620-2627 (2006).
27. Rocca, M. A, Mastronardo, G., Rodegher, M., Comi, G., Filippi, M. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am. J. Neuroradiol. 20, 821-827 (1999).
28. Filippi, M., Rocca, M. A. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 4, 401-413 (2007).
29. Hayton, T. et al. Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. J. Neurol. 256, 427-435 (2009).
30. Rovaris, M. et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult. Scler. 14, 455-464 (2008).
31. Ranjeva, J. P. et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am. J. Neuroradiol. 26, 119-127 (2005).
32. Amato, M. P. et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 71, 632-638 (2008).
33. Tur, C. et al. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Mult. Scler. 17, 1324-1332 (2011).
34. Khaleeli, Z. et al. Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch. Neurol. 65, 1454-1459 (2008).
35. Penny, S., Khaleeli, Z., Cipolotti, L., Thompson, A., Ron, M. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology 74, 545-552 (2010).
36. Filippi, M. et al. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology 81, 1759-1767 (2013).
37. Chen, J. T. et al. Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology 80, 246-252 (2013).
38. Samson, R. S. et al. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups. Mult. Scler. 20, 1322-1330 (2014).
39. Derakhshan, M., Caramanos, Z., Narayanan, S., Arnold, D. L., Louis Collins, D. Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination. Hum. Brain Mapp. 35, 3402-3413 (2014).
40. Basser, P. J., Mattiello, J., LeBihan, D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. B 103, 247-254 (1994).
41. Wheeler-Kingshott, C. A., Ciccarelli, O., Schneider, T., Alexander, D. C., Cercignani, M. A new approach to structural integrity assessment based on axial and radial diffusivities. Funct. Neurol. 27, 85-90 (2012).
42. Ferizi, U. et al. A ranking of diffusion MRI compartment models with in vivo human brain data. Magn. Reson. Med. 72, 1785-1792 (2014).
43. Zhang, H., Schneider, T., Wheeler-Kingshott, C. A., Alexander, D. C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61, 1000-1016 (2012).
44. Jelescu, I. O. et al. One diffusion acquisition and different white matter models: how does microstructure change in human early development based on WMTI and NODDI Neuroimage 107, 242-256 (2015).
45. Wang, Y. et al. Quantification of increased cellularity during inflammatory demyelination. Brain 134, 3590-3601 (2011).
46. Bester, M. et al. Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult. Scler. 21, 935-944 (2015).
47. Raz, E. et al. A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study. AJNR Am. J. Neuroradiol. 34, 1846-1852 (2013).
48. Palesi, F. et al. Contralateral cerebello-thalamo-cortical pathways with prominent involvement of associative areas in humans in vivo. Brain Struct. Funct. 220, 3369-3384 (2015).
49. Sherbondy, A. J., Rowe, M. C., Alexander, D. C. MicroTrack: an algorithm for concurrent projectome and microstructure estimation. Med. Image Comput. Comput. Assist. Interv. 13, 183-190 (2010).
50. Rovaris, M. et al. Diffusion MRI in multiple sclerosis. Neurology 65, 1526-1532 (2005).
51. Bodini, B., Ciccarelli, O. in Diffusion MRI: from Quantitative Measurement to In Vivo Neuroanatomy (eds Johansen-Berg, H., Behrens, T. E.) 175-203 (Elsevier, 2009).
52. Schmierer, K. et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 35, 467-477 (2007).
53. Seewann, A. et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch. Neurol. 66,601-609 (2009).
54. Bodini, B. et al. Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years. Hum. Brain Mapp. 34, 1163-1172 (2013).
55. Dineen, R. A. et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132, 239-249 (2009).
56. Schoonheim, M. M. et al. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 84, 776-783 (2015).
57. Hulst, H. E. et al. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology 80, 1025-1032 (2013).
58. Welton, T., Kent, D., Constantinescu, C. S., Auer, D. P., Dineen, R. A. Functionally relevant white matter degradation in multiple sclerosis: a tract-based spatial meta-analysis. Radiology 275, 89-96 (2015).
59. Mesaros, S. et al. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology 78, 969-975 (2012).
60. Shu, N. et al. Diffusion tensor tractography reveals disrupted topological efficiency in white matter structural networks in multiple sclerosis. Cereb. Cortex 21, 2565-2577 (2011).
61. Bodini, B. et al. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum. Brain Mapp. 30, 2852-2861 (2009).
62. Steenwijk, M. D. et al. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Hum. Brain Mapp. 36, 1796-1807 (2015).
63. Sbardella, E. et al. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS ONE 8, e63250 (2013).
64. Schenck, J. F. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med. Phys. 23, 815-850 (1996).
65. Ropele, S. et al. Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Mult. Scler. 20, 1692-1698 (2014).
66. Wang, Y., Liu, T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn. Reson. Med. 73, 82-101 (2015).
67. Langkammer, C. et al. Quantitative susceptibility mapping in multiple sclerosis. Radiology 267, 551-559 (2013).
68. Haacke, E. M., Mittal, S., Wu, Z., Neelavalli, J., Cheng, Y. C. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am. J. Neuroradiol. 30, 19-30 (2009).
69. Tallantyre, E. C. et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 76, 534-539 (2011).
70. Wuerfel, J. et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult. Scler. 18, 1592-1599 (2012).
71. Sinnecker, T. et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79, 708-714 (2012).
72. Kilsdonk, I. D. et al. Improved differentiation between MS and vascular brain lesions using FLAIR at 7 Tesla. Eur. Radiol. 24, 841-849 (2014).
73. Quinn, M. P., Kremenchutzky, M., Menon, R. S. Venocentric lesions: an MRI marker of MS Front. Neurol. 4, 98 (2013).
74. Hagemeier, J. et al. Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. AJNR Am. J. Neuroradiol. 35, 1916-1923 (2014).
75. Absinta, M. et al. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann. Neurol. 74, 669-678 (2013).
76. Chen, W. et al. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 271, 183-192 (2014).
77. Mehta, V. et al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS ONE 8, e57573 (2013).
78. Hametner, S. et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74, 848-861 (2013).
79. Williams, R., Buchheit, C. L., Berman, N. E., LeVine, S. M. Pathogenic implications of iron accumulation in multiple sclerosis. J. Neurochem. 120, 7-25 (2012).
80. Stankiewicz, J. M., Neema, M., Ceccarelli, A. Iron and multiple sclerosis. Neurobiol. Aging 35 (Suppl. 2), S51-S58 (2014).
81. Stephenson, E., Nathoo, N., Mahjoub, Y., Dunn, J. F., Yong, V. W. Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat. Rev. Neurol. 10, 459-468 (2014).
82. Langkammer, C. et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 257, 455-462 (2010).
83. Walsh, A. J. et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 267, 531-542 (2013).
84. Walsh, A. J. et al. Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 270, 186-196 (2014).
85. Khalil, M., et al. Dynamics of brain iron levels in multiple sclerosis: a longitudinal 3T MRI study. Neurology 84, 2396-2402 (2015).
86. Khalil, M. et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 77, 1691-1697 (2011).
87. MacKay, A. et al. In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med. 31, 673-677 (1994).
88. Prasloski, T. et al. Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence. Neuroimage 63, 533-539 (2012).
89. Laule, C. et al. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage 40, 1575-1580 (2008).
90. Levesque, I. R. et al. Quantitative magnetization transfer and myelin water imaging of the evolution of acute multiple sclerosis lesions. Magn. Reson. Med. 63, 633-640 (2010).
91. Craner, M. J. et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of NaV1.2 and NaV1.6 sodium channels and Na+/Ca2+ exchanger. Proc. Natl Acad. Sci. USA 101, 8168-8173 (2004).
92. Black, J. A., Newcombe, J., Waxman, S. G. Astrocytes within multiple sclerosis lesions upregulate sodium channel NaV1.5. Brain 133, 835-846 (2010).
93. Romanzetti, S. et al. Mapping tissue sodium concentration in the human brain: a comparison of MR sequences at 9.4Tesla. Neuroimage 96, 44-53 (2014).
94. Inglese, M. et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain 133, 847-857 (2010).
95. Basford, J. R. et al. Evaluation of healthy and diseased muscle with magnetic resonance elastography. Arch. Phys. Med. Rehabil. 83, 1530-1536 (2002).
96. Papazoglou, S., Rump, J., Braun, J., Sack, I. Shear wave group velocity inversion in MR elastography of human skeletal muscle. Magn. Reson. Med. 56, 489-497 (2006).
97. McKnight, A. L. et al. MR elastography of breast cancer: preliminary results. AJR Am. J. Roentgenol. 178, 1411-1417 (2002).
98. Asbach, P. et al. Assessment of liver viscoelasticity using multifrequency MR elastography. Magn. Reson. Med. 60, 373-379 (2008).
99. Muthupillai, R., Ehman, R. L. Magnetic resonance elastography. Nat. Med. 2, 601-603 (1996).
100. Green, M. A., Bilston, L. E., Sinkus, R. In vivo brain viscoelastic properties measured by magnetic resonance elastography. NMR Biomed. 21, 755-764 (2008).
101. Kruse, S. A. et al. Magnetic resonance elastography of the brain. Neuroimage 39, 231-237 (2008).
102. Sack, I., Beierbach, B., Hamhaber, U., Klatt, D., Braun, J. Non-invasive measurement of brain viscoelasticity using magnetic resonance elastography. NMR Biomed. 21, 265-271 (2008).
103. Sack, I. et al. The impact of aging and gender on brain viscoelasticity. Neuroimage 46, 652-657 (2009).
104. Wuerfel, J. et al. MR-elastography reveals degradation of tissue integrity in multiple sclerosis. Neuroimage 49, 2520-2525 (2010).
105. Pittock, S. J., Lucchinetti, C. F. The pathology of MS: new insights and potential clinical applications. Neurologist 13, 45-56 (2007).
106. Streitberger, K. J. et al. Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS ONE 7, e29888 (2012).
107. Schregel, K. et al. Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography. Proc. Natl Acad. Sci. USA 109, 6650-6655 (2012).
108. Paling, D. et al. Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability. J. Cereb. Blood Flow Metab. 34, 34-42 (2014).
109. Rashid, W. et al. Abnormalities of cerebral perfusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75, 1288-1293 (2004).
110. Law, M. et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231, 645-652 (2004).
111. Adhya, S. et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33, 1029-1035 (2006).
112. Filippi, M. et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann. Neurol. 43, 499-506 (1998).
113. Barkhof, F. et al. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat. Rev. Neurol. 8, 13-21 (2011).
114. De Stefano, N. et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 74, 1868-1876 (2010).
115. Rocca, M. A. et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J. Neurol. 255, 683-691 (2008).
116. Pagani, E. et al. Intercenter differences in diffusion tensor MRI acquisition. J. Magn. Reson. Imaging 31, 1458-1468 (2010).
117. Ropele, S. et al. Assessment and correction of B1-induced errors in magnetization transfer ratio measurements. Magn. Reson. Med. 53, 134-140 (2005).
118. Inglese, M. et al. The effect of interferon-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 60, 853-860 (2003).
119. Filippi, M. et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch. Neurol. 61, 1409-1412 (2004).
120. Narayanan, S. et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon-1b. J. Neurol. 248, 979-986 (2001).
121. Sajja, B. R., Narayana, P. A., Wolinsky, J. S., Ahn, C. W. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study. Mult. Scler. 14, 73-80 (2008).
122. van den Elskamp, I. J. et al. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. Mult. Scler. 16, 660-669 (2010).
123. Brown, R. A., Narayanan, S., Arnold, D. L. Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis. Neuroimage 66, 103-109 (2013).
124. Zivadinov, R. et al. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFN-1a in multiple sclerosis. Mult. Scler. 18, 1125-1134 (2012).
125. Button, T. et al. Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab. Mult. Scler. 19, 241-244 (2013).
126. Filippi, M. et al. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. J. Neurol. Neurosurg. Psychiatry 85, 851-858 (2014).
127. Hayton, T. et al. Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. J. Neurol. 259, 505-514 (2012).
128. Bonzano, L. et al. Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis. Neuroimage 90, 107-116 (2014).
129. Prosperini, L. et al. Multiple sclerosis: changes in microarchitecture of white matter tracts after training with a video game balance board. Radiology 273, 529-538 (2014).
130. Horsfield, M. A. et al. Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J. Magn. Reson. Imaging 17, 389-397 (2003).
131. Pagani, E. et al. Diffusion MR imaging in multiple sclerosis: technical aspects and challenges. AJNR Am. J. Neuroradiol. 28, 411-420 (2007).